Bloomberg Intelligence cover image

BI Weekend: Nvidia Earnings, Paramount Saga

Bloomberg Intelligence

CHAPTER

Eli Lilly's Strategic Shift and Port Dynamics

This chapter examines Eli Lilly's decision to discount its drug ZEPBOUND to address supply shortages and enhance patient access while navigating market competition. It also explores the rise in cargo imports at the Port of Los Angeles, the challenges faced in the shipping industry, and the implications of federal investment in port infrastructure. Additionally, the discussion touches on geopolitical impacts on trade and shifts in reliance from Chinese to Southeast Asian goods.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner